Evidence map›Paper›PMID 36572728›Full record

ArticleBone marrow transplantation2023

Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Shun-Ichi Kimura, Hiroaki Shimizu, Takuya Miyazaki, Masatoshi Sakurai, Susumu Tanoue, Kensuke Kayamori, Chikako Ohwada, Kazuki Yoshimura, Hideki Nakasone, Takuma Ohashi and 12 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 14 institutions in 1 country.

Shun-Ichi KimuraDivision of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.ORCID 0000-0001-9827-8526
Hiroaki ShimizuHematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Takuya MiyazakiDepartment of Hematology, Yokohama City University Medical Center, Kanagawa, Japan.
Masatoshi SakuraiDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0002-6687-4136
Susumu TanoueDivision of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Kensuke KayamoriDepartment of Hematology, Chiba University Hospital, Chiba, Japan.ORCID 0000-0001-6140-3135
Chikako OhwadaDepartment of Hematology, Chiba University Hospital, Chiba, Japan.ORCID 0000-0001-9648-940X
Kazuki YoshimuraDivision of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.ORCID 0000-0002-8013-1400
Hideki NakasoneDivision of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.ORCID 0000-0001-5812-9315
Takuma OhashiDepartment of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Kanagawa, Japan.ORCID 0000-0002-4354-2032
Katsuhiro ShonoDepartment of Hematology, Aoba Municipal Hospital, Chiba, Japan.ORCID 0000-0002-5163-0163
Takayoshi TachibanaDepartment of Hematology, Kanagawa Cancer Center, Kanagawa, Japan.ORCID 0000-0002-7780-4459
Kaoru HatanoDivision of Hematology, Jichi Medical University, Tochigi, Japan.
Keigo OkadaDepartment of Hematology, Tokyo Medical and Dental University, Tokyo, Japan.
Yuta KimuraDepartment of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Sachiko SeoDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
Noriko DokiHematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Masatsugu TanakaDepartment of Hematology, Kanagawa Cancer Center, Kanagawa, Japan.
Yoshihiro HattaDepartment of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
Satoshi TakahashiDivision of Clinical Precision Research Platform, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan.ORCID 0000-0002-1076-2338
Yoshinobu KandaDivision of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. ycanda-tky@umin.ac.jp.ORCID 0000-0002-4866-9307
Kanto Study Group for Cell Therapy
Jichi Medical University · JPChiba University Hospital · JPKanagawa Prefectural Hospital Organization · JPTokyo Metropolitan Komagome Hospital · JPChiba Aoba Municipal Hospital · JPDokkyo Medical University · JPJikei University School of Medicine · JPKeio University · JPNihon University · JPSocial Insurance Saitama Chuo Hospital · JPThe University of Tokyo · JPTokyo Medical and Dental University · JPYokohama City University · JPYokohama City University Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dipeptidyl-Peptidase IV InhibitorsGraft vs Host DiseaseHematopoietic Stem Cell TransplantationDipeptidyl-Peptidases and Tripeptidyl-PeptidasesHumansIncidenceDipeptidyl-Peptidase IV InhibitorsDipeptidyl-Peptidases and Tripeptidyl-Peptidases

Identifiers

PMID36572728
OpenAlexW4312212141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.